Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Robert L. Doyle, M.D., D.D.S.

Title
Institution
Department
Address
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Conti C, Fontanesi L, Lanzara R, Rosa I, Doyle RL, Porcelli P. Burnout Status of Italian Healthcare Workers during the First COVID-19 Pandemic Peak Period. Healthcare (Basel). 2021 Apr 28; 9(5). PMID: 33925215.
    Citations:    
  2. Goetz M, Schwabova J, Hlavka Z, Ptacek R, Zumrova A, Hort V, Doyle R. Cerebellar Symptoms Are Associated With Omission Errors and Variability of Response Time in Children With ADHD. J Atten Disord. 2017 02; 21(3):190-199. PMID: 24412970.
    Citations: 6     Fields:    Translation:Humans
  3. Theoharides TC, Athanassiou M, Panagiotidou S, Doyle R. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. J Neuroimmunol. 2015 Feb 15; 279:33-8. PMID: 25669997.
    Citations: 20     Fields:    Translation:HumansCells
  4. Hammerness P, Joshi G, Doyle R, Georgiopoulos A, Geller D, Spencer T, Petty CR, Faraone SV, Biederman J. Do stimulants reduce the risk for cigarette smoking in youth with attention-deficit hyperactivity disorder? A prospective, long-term, open-label study of extended-release methylphenidate. J Pediatr. 2013 Jan; 162(1):22-7.e2. PMID: 22878114.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  5. Surman CB, Hammerness PG, Petty C, Spencer T, Doyle R, Napolean S, Chu N, Yorks D, Biederman J. A pilot open label prospective study of memantine monotherapy in adults with ADHD. World J Biol Psychiatry. 2013 May; 14(4):291-8. PMID: 22436083.
    Citations: 7     Fields:    Translation:Humans
  6. Joshi G, Petty CR, Fried R, Wozniak J, Micco JA, Henin A, Doyle R, Galdo M, Kotarski M, Caruso J, Meller B, Faraone SV, Biederman J. Discriminant and concurrent validity of a simplified DSM-based structured diagnostic instrument for the assessment of autism spectrum disorders in youth and young adults. BMC Psychiatry. 2011 Dec 30; 11:204. PMID: 22208391.
    Citations: 2     Fields:    Translation:Humans
  7. Joshi G, Petty C, Wozniak J, Faraone SV, Doyle R, Georgiopoulos A, Hammerness P, Walls S, Glaeser B, Brethel K, Yorks D, Biederman J. A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder. J Affect Disord. 2012 Feb; 136(3):1143-53. PMID: 22035648.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  8. Joshi G, Biederman J, Wozniak J, Doyle R, Hammerness P, Galdo M, Sullivan N, Williams C, Brethel K, Woodworth KY, Mick E. Response to second generation antipsychotics in youth with comorbid bipolar disorder and autism spectrum disorder. CNS Neurosci Ther. 2012 Jan; 18(1):28-33. PMID: 21114638.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  9. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Kotarski M, Spencer T. A randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2010 Oct; 30(5):549-53. PMID: 20814332.
    Citations: 27     Fields:    Translation:HumansCellsCTClinical Trials
  10. Biederman J, Petty CR, Fried R, Wozniak J, Micco JA, Henin A, Doyle R, Joshi G, Galdo M, Kotarski M, Caruso J, Yorks D, Faraone SV. Child behavior checklist clinical scales discriminate referred youth with autism spectrum disorder: a preliminary study. J Dev Behav Pediatr. 2010 Jul-Aug; 31(6):485-90. PMID: 20585266.
    Citations: 20     Fields:    Translation:Humans
  11. Spencer TJ, Mick E, Surman CB, Hammerness P, Doyle R, Aleardi M, Kotarski M, Williams CG, Biederman J. A randomized, single-blind, substitution study of OROS methylphenidate (Concerta) in ADHD adults receiving immediate release methylphenidate. J Atten Disord. 2011 May; 15(4):286-94. PMID: 20495161.
    Citations: 8     Fields:    Translation:Humans
  12. Wilens TE, Prince JB, Waxmonsky J, Doyle R, Spencer T, Martelon M, Evans M. An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders. J ADHD Relat Disord. 2010 Apr 01; 1(3):25-35. PMID: 22500195.
    Citations: 5     
  13. Biederman J, Joshi G, Mick E, Doyle R, Georgiopoulos A, Hammerness P, Kotarski M, Williams C, Wozniak J. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther. 2010 Apr; 16(2):91-102. PMID: 20415838.
    Citations: 9     Fields:    Translation:Humans
  14. Joshi G, Wozniak J, Mick E, Doyle R, Hammerness P, Georgiopoulos A, Kotarski M, Aleardi M, Williams C, Walls S, Biederman J. A prospective open-label trial of extended-release carbamazepine monotherapy in children with bipolar disorder. J Child Adolesc Psychopharmacol. 2010 Feb; 20(1):7-14. PMID: 20166791.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  15. Surman C, Hammerness P, Petty C, Doyle R, Chu N, Gebhard N, Williams C, Biederman J. Atomoxetine in the treatment of adults with subthreshold and/or late onset attention-deficit hyperactivity disorder-not otherwise specified (ADHD-NOS): a prospective open-label 6-week study. CNS Neurosci Ther. 2010; 16(1):6-12. PMID: 20070786.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  16. Hammerness P, Georgiopoulos A, Doyle RL, Utzinger L, Schillinger M, Martelon M, Brodziak K, Biederman J, Wilens TE. An open study of adjunct OROS-methylphenidate in children who are atomoxetine partial responders: II. Tolerability and pharmacokinetics. J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):493-9. PMID: 19877973.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  17. McCorry NK, Dempster M, Clarke C, Doyle R. Adjusting to life after esophagectomy: the experience of survivors and carers. Qual Health Res. 2009 Oct; 19(10):1485-94. PMID: 19805810.
    Citations: 14     Fields:    Translation:Humans
  18. Wilens TE, Hammerness P, Utzinger L, Schillinger M, Georgiopoulous A, Doyle RL, Martelon M, Brodziak K. An open study of adjunct OROS-methylphenidate in children and adolescents who are atomoxetine partial responders: I. Effectiveness. J Child Adolesc Psychopharmacol. 2009 Oct; 19(5):485-92. PMID: 19877972.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  19. Hammerness P, Wilens T, Mick E, Spencer T, Doyle R, McCreary M, Becker J, Biederman J. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder. J Pediatr. 2009 Jul; 155(1):84-9, 89.e1. PMID: 19394037.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  20. Hammerness P, Doyle R, Kotarski M, Georgiopoulos A, Joshi G, Zeitlin S, Biederman J. Atomoxetine in children with attention-deficit hyperactivity disorder with prior stimulant therapy: a prospective open-label study. Eur Child Adolesc Psychiatry. 2009 Aug; 18(8):493-8. PMID: 19377865.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  21. Zamanian RT, Hansmann G, Snook S, Lilienfeld D, Rappaport KM, Reaven GM, Rabinovitch M, Doyle RL. Insulin resistance in pulmonary arterial hypertension. Eur Respir J. 2009 Feb; 33(2):318-24. PMID: 19047320.
    Citations: 107     Fields:    Translation:Humans
  22. Theoharides TC, Doyle R. Autism, gut-blood-brain barrier, and mast cells. J Clin Psychopharmacol. 2008 Oct; 28(5):479-83. PMID: 18794641.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  23. Brams M, Mao AR, Doyle RL. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. Postgrad Med. 2008 Sep; 120(3):69-88. PMID: 18824827.
    Citations: 4     Fields:    Translation:Humans
  24. Theoharides TC, Doyle R, Francis K, Conti P, Kalogeromitros D. Novel therapeutic targets for autism. Trends Pharmacol Sci. 2008 Aug; 29(8):375-82. PMID: 18606459.
    Citations: 18     Fields:    Translation:HumansCells
  25. Biederman J, Hammerness P, Doyle R, Joshi G, Aleardi M, Mick E. Risperidone treatment for ADHD in children and adolescents with bipolar disorder. Neuropsychiatr Dis Treat. 2008 Feb; 4(1):203-7. PMID: 18728799.
    Citations: 7     
  26. Domizio S, Conte E, Puglielli C, Domizio R, Verrotti A, Pollice R, Casacchia M, Conti CM, Roncone R, Sabatino G, Doyle R, Barbacane RC, Conti P, Sabatino G. Epileptic EEG discharges and short non-convulsive crisis: Influence on cognitive and psychobehavioural functions in youths. Clin Invest Med. 2008; 31(1):E20-40. PMID: 18312745.
    Citations:    Fields:    Translation:Humans
  27. Biederman J, Mick EO, Surman C, Doyle R, Hammerness P, Michel E, Martin J, Spencer TJ. Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. BMC Psychiatry. 2007 Sep 14; 7:49. PMID: 17868455.
    Citations: 12     Fields:    Translation:Humans
  28. Biederman J, Mick E, Spencer T, Doyle R, Joshi G, Hammerness P, Kotarski M, Aleardi M, Wozniak J. An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorder. CNS Spectr. 2007 Sep; 12(9):683-9. PMID: 17805214.
    Citations: 19     Fields:    Translation:Humans
  29. Doyle R, Mick E, Biederman J. Convergence between the Achenbach youth self-report and structured diagnostic interview diagnoses in ADHD and non-ADHD youth. J Nerv Ment Dis. 2007 Apr; 195(4):350-2. PMID: 17435486.
    Citations: 4     Fields:    Translation:Humans
  30. Tumini E, Porcellini E, Chiappelli M, Conti CM, Beraudi A, Poli A, Caciagli F, Doyle R, Conti P, Licastro F. The G51S purine nucleoside phosphorylase polymorphism is associated with cognitive decline in Alzheimer's disease patients. Hum Psychopharmacol. 2007 Mar; 22(2):75-80. PMID: 17221831.
    Citations: 1     Fields:    Translation:Humans
  31. Dalessandro M, Conti CM, Gambi F, Falasca K, Doyle R, Conti P, Caciagli F, Fulcheri M, Vecchiet J. Antidepressant therapy can improve adherence to antiretroviral regimens among HIV-infected and depressed patients. J Clin Psychopharmacol. 2007 Feb; 27(1):58-61. PMID: 17224714.
    Citations: 18     Fields:    Translation:Humans
  32. Geller DA, Doyle R, Shaw D, Mullin B, Coffey B, Petty C, Vivas F, Biederman J. A quick and reliable screening measure for OCD in youth: reliability and validity of the obsessive compulsive scale of the Child Behavior Checklist. Compr Psychiatry. 2006 May-Jun; 47(3):234-40. PMID: 16635654.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  33. Biederman J, Mick E, Spencer T, Surman C, Hammerness P, Doyle R, Dougherty M, Aleardi M, Schweitzer K. An open-label trial of OROS methylphenidate in adults with late-onset ADHD. CNS Spectr. 2006 May; 11(5):390-6. PMID: 16641844.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  34. Doyle RL, Frazier J, Spencer TJ, Geller D, Biederman J, Wilens T. Donepezil in the treatment of ADHD-like symptoms in youths with pervasive developmental disorder: a case series. J Atten Disord. 2006 Feb; 9(3):543-9. PMID: 16481671.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  35. Biederman J, Mick E, Surman C, Doyle R, Hammerness P, Harpold T, Dunkel S, Dougherty M, Aleardi M, Spencer T. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2006 May 01; 59(9):829-35. PMID: 16373066.
    Citations: 73     Fields:    Translation:HumansCTClinical Trials
  36. Bersani G, Gherardelli S, Clemente R, Di Giannantonio M, Grilli A, Conti CM, Exton MS, Conti P, Doyle R, Pancheri P. Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics. J Clin Psychopharmacol. 2005 Aug; 25(4):372-5. PMID: 16012282.
    Citations: 6     Fields:    Translation:Humans
  37. Spencer T, Biederman J, Wilens T, Doyle R, Surman C, Prince J, Mick E, Aleardi M, Herzig K, Faraone S. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Mar 01; 57(5):456-63. PMID: 15737659.
    Citations: 82     Fields:    Translation:HumansCTClinical Trials
  38. Coffey BJ, Biederman J, Geller D, Frazier J, Spencer T, Doyle R, Gianini L, Small A, Frisone DF, Magovcevic M, Stein N, Faraone SV. Reexamining Tic persistence and Tic-associated impairment in Tourette's Disorder: findings from a naturalistic follow-up study. J Nerv Ment Dis. 2004 Nov; 192(11):776-80. PMID: 15505522.
    Citations: 18     Fields:    Translation:Humans
  39. Doyle R. The history of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004 Jun; 27(2):203-14. PMID: 15063993.
    Citations: 3     Fields:    Translation:Humans
  40. Geller DA, Biederman J, Faraone S, Spencer T, Doyle R, Mullin B, Magovcevic M, Zaman N, Farrell C. Re-examining comorbidity of Obsessive Compulsive and Attention-Deficit Hyperactivity Disorder using an empirically derived taxonomy. Eur Child Adolesc Psychiatry. 2004 Apr; 13(2):83-91. PMID: 15103533.
    Citations: 10     Fields:    Translation:Humans
  41. Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder. Biol Psychiatry. 2003 Jul 01; 54(1):9-16. PMID: 12842303.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  42. Huang SH, Gambi F, Conti F, Carratelli G, Conti CM, Mastromauro I, Riccioni G, Grilli A, Bellati U, Doyle RL. Antiepileptic drugs lower contraceptive sex hormone and increase the risk of unplanned pregnancies in women with epilepsy: revisited study. Int J Immunopathol Pharmacol. 2003 May-Aug; 16(2):181-3. PMID: 12797910.
    Citations: 1     Fields:    Translation:Humans
  43. Frazier JA, Doyle R, Chiu S, Coyle JT. Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry. 2002 Jan; 159(1):13-21. PMID: 11772683.
    Citations: 6     Fields:    Translation:Humans
  44. Spencer T, Biederman J, Wilens T, Faraone S, Prince J, Gerard K, Doyle R, Parekh A, Kagan J, Bearman SK. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 2001 Aug; 58(8):775-82. PMID: 11483144.
    Citations: 51     Fields:    Translation:HumansCTClinical Trials
  45. Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001 Feb; 158(2):282-8. PMID: 11156812.
    Citations: 37     Fields:    Translation:HumansCTClinical Trials
  46. Porta R, Doyle RL, Tatter SB, Wilens TE, Schatz RA, Sellinger OZ. The biosynthesis of polyamines in the brain of audiogenic seizure-susceptible and -resistant deermice. J Neurochem. 1981 Sep; 37(3):723-9. PMID: 7276952.
    Citations: 1     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Doyle's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (203)
Explore
_
Co-Authors (20)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.